Most Antibody Drugs Ineffective Against Brazil Variant

(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody

Read more

Model of SARS-CoV-2 Spike Protein Reveals Potential Vaccine Targets

NEW YORK (Reuters Health) – Dynamic molecular simulations that captured the structure and movements of the SARS-CoV-2 spike protein have

Read more

COVID Pandemic Increased Stillbirth and Maternal Death Rates: Study

(Reuters) – Rates of stillbirth and maternal deaths rose by around a third during the COVID-19 pandemic, with pregnancy outcomes

Read more

Virginia Law Denies Benefit to Some Healthcare Workers Who Refuse COVID-19 Vaccine

(Reuters) – Virginia has passed a law making it easier for some healthcare workers who become ill with COVID-19 to

Read more

GM-CSF Pinpointed as Possible Therapeutic Target for COVID-19

NEW YORK (Reuters Health) – Granulocyte-macrophage colony-stimulating factor (GM-CSF) seems to play a key role in severe COVID-19 inflammation, supporting

Read more

Countries Resuming Use of AstraZeneca Vaccine After Blood Clot Investigation

(Reuters) – Many countries are resuming use of AstraZeneca’s COVID-19 vaccine after the European Medicines Agency and the World Health

Read more

Most Americans Who Got First COVID-19 Vaccine Dose Also Got Final Shot: CDC

(Reuters) – Vaccination of about 88% of Americans who received the first dose of Pfizer/BioNTech or Moderna’s COVID-19 vaccines was

Read more

EU COVID-19 Travel Certificates Must Prevent ‘Discrimination’, Document Shows

BRUSSELS (Reuters) – European Union COVID-19 certificates intended to free up travel must prevent discrimination against those not vaccinated by

Read more

After Year of Isolation, Vaccinated Older Americans Start to Reclaim Their Lives

NEW YORK (Reuters) – Precisely two weeks after receiving her second COVID-19 vaccine shot, Sylvia Baer spent the day getting

Read more